Immune cell therapies have transformed the treatment of certain blood cancers over the past decade. However, when it comes to ...

Artiva advances NK cell therapy to phase 3, secures 400 billion won funding Single phase 3 cleared by FDA after strong phase ...

Founder Patrick Soon-Shiong hinted at expansion plans in Turkey, saying on X that “Global expansion” is underway. ・Soon-Shiong also revealed that ImmunityBio’s AI-driven NK-cell manufacturing robot is ...

One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells. Similar to CAR-T cells, these cells can be ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, manufacturing complexity, and limited effectiveness against solid tumors.

Natural Killer (NK) cells are vital immune defenders that target and destroy cancer cells. However, in aging and cancer patients, NK cells often become "senescent"—losing their effectiveness due to ...

(A) Unsupervised consistent clustering of the two subtypes of TCGA-HCC patients. (B) Comparison of overall survival (OS) between the two subtypes of TCGA-HCC patients. (C) Comparison of MIAS scores ...

Founder Patrick Soon-Shiong said the company’s AI-powered immune cell manufacturing robot is already in production. ・The “world’s first” NK-cell manufacturing robot uses AI and machine learning to ...

Eosinophils and mast cells are two types of immune cells with critical roles in responding to foreign assaults. When these cells do not function properly, several disease outcomes can develop (e.g.

NK-CHAT may help detect antibody-mediated rejection earlier after kidney transplantation by measuring functional NK cell ...